Commercial health insurance plans and plans offered to federal employees must send reports to the US government beginning in late 2022 on several aspects of the cost, including rebates, associated with retail pharmacy drugs. But they will only have to report total annual spending on drugs covered under the medical or hospital benefit, under an interim final rule published in the 23 November Federal Register.
The rule, issued by the departments of Health and Human Services, Labor and Treasury, implements provisions of the Consolidations Appropriations Act of 2020, which mandated transparency requirements for health plan spending on prescription drugs as well as other health care services